| Ropivacaine 0.25% and 0.5%, but not 0.125%, provide effective wound infiltration analgesia after outpatient hernia repair, but with sustained plasma drug levels. | |
| | |
MedLine Citation:
|
PMID: 10204899 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVES: Ropivacaine is a long-acting local anesthetic similar to bupivacaine, but with lower cardiac toxicity and intrinsic vasoconstrictive properties that may reduce the risk and extent of systemic plasma absorption. Plasma levels and risks are associated with the total dose used and the extent of absorption, with lower doses potentially representing less risk. Although both 0.5% and 0.75% ropivacaine provide adequate analgesia for wound infiltration after hernia repair, the efficacy of lower doses and the early systemic absorption have not been reported. METHODS: We studied postoperative pain and systemic plasma levels following either the injection of 30 mL of saline or 0.125%, 0.25%, or 0.5% ropivacaine into the wounds in 110 healthy patients following hernia repair under spinal anesthesia. Pain was assessed using visual analog scale (VAS) scores and algometer readings at rest and after coughing, and oral analgesic requirements were assessed in the first 5 hours after surgery and for the week after discharge. RESULTS: Both 0.25% and 0.5% ropivacaine provided pain relief following surgery when compared with saline or 0.125%. No adverse reactions to the drug were reported in any group. Plasma levels of ropivacaine peaked between 30 and 60 minutes, at 0.109, 0.249, and 0.399 mg/L for 0.125%, 0.25%, and 0.5% concentrations, respectively. Although the levels were below those producing clinical symptoms, they remained elevated for the entire 2-hour sampling period. This implies an absorption-dependent elimination which is substantially longer than reported with other routes of injection. CONCLUSIONS: Ropivacaine 0.25% and 0.5% is adequate for pain relief after outpatient hernia repair, whereas the 0.125% solution is no more effective than saline. Prolonged systemic absorption from peripheral injection may be associated with prolonged elevations of plasma concentrations, which potentially could be associated with unexpectedly high plasma levels if repeated injections are performed in the perioperative period with higher concentrations or doses. |
| | |
Authors:
|
M F Mulroy; F W Burgess; B M Emanuelsson |
Related Documents
:
|
10030309 - Evaluating the appropriateness of digoxin level monitoring. 3360049 - Serum doxapram and respiratory neuromuscular drive in normal man. 12693599 - Digoxin toxicity in thai medical patients: clinical manifestations and an appropriate d... 21121879 - Do we need to optimize plasma protein and tissue binding in drug discovery? 1188169 - Altered tissue digoxin uptake after a toxic dose. 1655319 - Digoxin-like immunoreactivity increases with intravenous infusion of saline in rats. 7593849 - Pharmacokinetics and tissue uptake of d-alpha-tocopherol in sheep following a single in... 11076089 - Effect of hepatocyte growth factor on sperm motility. 1109519 - Extravascular fibrinogen degradation in experimental burn wounds: a source of fibrin sp... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Regional anesthesia and pain medicine Volume: 24 ISSN: 1098-7339 ISO Abbreviation: Reg Anesth Pain Med Publication Date: 1999 Mar-Apr |
Date Detail:
|
Created Date: 1999-06-08 Completed Date: 1999-06-08 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9804508 Medline TA: Reg Anesth Pain Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 136-41 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology, Virginia Mason Medical Center, Seattle, Washington, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Absorption Adult Aged Amides / adverse effects, blood*, pharmacokinetics Analgesia / methods* Anesthetics, Local / adverse effects, blood*, pharmacokinetics Dose-Response Relationship, Drug Hernia, Inguinal / surgery* Humans Male Middle Aged Outpatients Pain, Postoperative / drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Amides; 0/Anesthetics, Local; 84057-95-4/ropivacaine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of 0.5% articaine and 0.5% prilocaine in intravenous regional anesthesia of the arm: a cr...
Next Document: Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: a randomize...